Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04840056 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis

Study acronym: GIMA
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Dec 1, 2025 → Dec 1, 2026
See other at-risk trials from Chinese University of Hong Kong

Record History

  1. Primary completion pushed from Dec 1, 2025 to Dec 1, 2026 Trial status changed: Unknown → Recruiting · Completion pushed from Dec 31, 2025 to Dec 31, 2026 · Eligibility criteria expanded, about 2 words Show 3 more changesShow less
    • Trial status changed: Unknown → Recruiting
    • Completion pushed from Dec 31, 2025 to Dec 31, 2026
    • Eligibility criteria expanded, about 2 words
  2. Changed Registry marked status Unknown; last known: Recruiting
  3. Trial status: Recruiting to Unknownv4
  4. Primary completion date: Mar 14, 2022 to Dec 1, 2025 Completion date: Sep 14, 2022 to Dec 31, 2025v3 Show 1 more changeShow less
    • Completion date: Sep 14, 2022 to Dec 31, 2025
  5. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1v2 Show 1 more changeShow less
    • Study sites: 0 to 1
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objectives of this study are: * To identify clinical or histological factors associated with gastric cancer development in patients with IM and AG * To establish a machine learning algorithm for prediction of future gastric cancer risks and individual risk stratification in patient with IM and AG
Trial Details
NCT Number NCT04840056
Lead Sponsor Chinese University of Hong Kong
Conditions Gastric Cancer, Intestinal Metaplasia, Atrophic Gastritis
Enrollment 1,300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov